Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.
Cancer Genome Evolution Research Group, University College London Cancer Institute, University College London, London, United Kingdom.
Cancer Discov. 2020 Sep;10(9):1263-1266. doi: 10.1158/2159-8290.CD-20-0823. Epub 2020 Jul 15.
The COVID-19 pandemic has caused widespread disruption of cancer clinical trials due to the restrictions on nonessential services and the reallocation of resources, and at the same time the urgent global effort toward discovering therapies that treat or prevent COVID-19 infection has led to shortening of traditional regulatory timelines. This experience should stimulate similar urgency in the way future cancer research is conducted.
由于限制非必要服务和资源重新分配,COVID-19 大流行导致癌症临床试验广泛中断,同时,全球迫切需要发现治疗或预防 COVID-19 感染的疗法,这导致传统监管时间线缩短。这种经验应该激发未来癌症研究开展方式的类似紧迫感。